Tristel plc (TSNLF)

Market Cap	265.78M +9.0%
Revenue (ttm)	66.67M +13.7%
Net Income	10.58M +28.1%
EPS	0.22 +26.1%
Shares Out	n/a
PE Ratio	25.11
Forward PE	20.96
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	5.74
Previous Close	5.74
Day's Range	5.74 - 5.74
52-Week Range	5.00 - 6.00
Beta	0.35
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 12, 2026

About Tristel

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for Stella, rinse assure, clean, EVE, medistel, EVA system, daisygrip, fuse for surfaces, dosing system, airstel, enzystel, DOK, pre-clean wipes, rinse wip...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1993
• Employees: 270
• Stock Exchange: OTCMKTS
• Ticker Symbol: TSNLF

Financial Performance

In fiscal year 2025, Tristel's revenue was 46.46 million, an increase of 10.80% compared to the previous year's 41.93 million. Earnings were 6.64 million, an increase of 2.33%.

Financial numbers in GBP

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 11, 2026

Data Sources Report a data error